• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Emergent BioSolutions Inc. Common Stock (NY:EBS)

    8.150 -2.950 (-26.58%)
    Official Closing Price Updated: 7:00 PM EST, Feb 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Emergent BioSolutions Inc. Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    17 18 Next >
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today? ↗
    The board authorized a new $50 million share repurchase program running through March 2027. 
    Via Stocktwits
    Topics Earnings
    Emergent BioSolutions Inc (NYSE:EBS) Shares Tumble on Weak Q4 Results and Cautious 2026 Outlook ↗
    Via Chartmill
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For October 29, 2025 ↗
     
    Via Benzinga
    News headline image
    Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada’s Leadership in Health Preparedness
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Why Did EBS Stock Fall 13% Today? ↗
    New York State Attorney General Letitia James inked a settlement with Emergent under which the company will pay $900,000 in penalties. 
    Via Stocktwits
    Topics Law Enforcement Lawsuit
    News headline image
    Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions (EBS) Earnings Transcript ↗
    Emergent BioSolutions (EBS) Earnings Transcript 
    Via The Motley Fool
    Topics Bonds Earnings
    News headline image
    These stocks are moving in today's session ↗
    Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
    Via Chartmill
    News headline image
    Here are the top movers in Thursday's session. ↗
    Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    The market is filled with gapping stocks in Thursday's session. ↗
    Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
    Via Chartmill
    News headline image
    Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗
     
    Via Benzinga
    News headline image
    Retail Traders Turn Ultra-Bullish On Emergent BioSolutions After Surprise Q3 Profit ↗
    Shares of Emergent BioSolutions jumped 18% in after-hours trading after the company posted stronger-than-expected Q3 results and raised its full-year guidance. 
    Via Stocktwits
    News headline image
    What's going on in today's after hours session ↗
    The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Emergent BioSolutions Reports Third Quarter 2025 Financial Results
    From Emergent BioSolutions
    Via GlobeNewswire
    News headline image
    Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
    Policy opinion leaders believe a biological attack is both more likely and easier to execute than a nuclear strike, highlighting concerns around bioterrorism and the nation’s readiness to respond 
    From Emergent BioSolutions
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    17 18 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.